Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma

Biochemical and Biophysical Research Communications

Volumn 314, Issue 4, 2004, Pages 1133-1140

  Shimoji, Takashi ^a,b,c   Kanda, Hiroaki ^d   Kitagawa, Tomoyuki ^d   Kadota, Koji ^e   Asai, Ryoichi ^e   Takahashi, Katsutoshi ^e   Kawaguchi, Noriyoshi ^c   Matsumoto, Seiichi ^c   Hayashizaki, Yoshihide ^b   Okazaki, Yasushi ^b,f   Shinomiya, Kenichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

^d CANCER INSTITUTE   (Japan)

^e NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

cDNA microarray; Dedifferentiated liposarcoma; Dedifferentiation; Diagnosis; Gene expression profile; Liposarcoma; Malignant potential; Well differentiated liposarcoma

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER GENETICS; CONTROLLED STUDY; DEDIFFERENTIATED LIPOSARCOMA; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIPOSARCOMA; METHODOLOGY; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TIME; TUMOR; WELL DIFFERENTIATED LIPOSARCOMA;

EID: 9144268271     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.203     Document Type: Article

References (29)

1. Weiss S.W., Goldblum J.R. Soft tissue tumors. 2001;Mosby, St Louis, United States.
2. Evans H.L. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am. J. Surg. Pathol. 3:1979;507-523.
3. Hashimoto H., Daimaru Y., Tuneyoshi M., Enjoji M. Soft tissue sarcoma with additional anaplastic components: a clinicopathologic and immunohistochemical study of 27 cases. Cancer. 66:1990;1578-1589.
4. Lucas D.R., Nascimento A.G., Sanjay B.K., Rock M.G. Well-differentiated liposarcoma: Mayo Clinic experience with 58 cases. Am. J. Clin. Pathol. 102:1994;677-683.
5. Weiss S.W., Rao V.K. Well differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum and miscellaneous sites: a follow-up study of 92 cases with analysis of the incidence of "dedifferentiation" Am. J. Surg. Pathol. 16:1992;1051-1058.
6. Hendricks W.H., Chu Y.C., Goldblum J.R., Weiss S.W. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am. J. Surg. Pathol. 21:1997;271-281.
7. Fletcher C.D.M., Unni K.K., Mertens F. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Soft Tissue and Bone. 2002;IARC Press, Lyon, France.
8. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J. Jr., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
9. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
10. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., Lizyness M.L., Kuick R., Hayasaka S., Taylor J.M., Iannettoni M.D., Orringer M.B., Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8:2002;816-824.
11. Hegde P., Qi R., Gaspard R., Abernathy K., Dharap S., Earle-Hughes J., Gay C., Nwokekeh N.U., Chen T., Saeed A.I., Sharov V., Lee N.H., Yeatman T.J., Quackenbush J. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Can. Res. 61:2001;7792-7797.
12. Van Gelder R.N., von Zastrow M.E., Yool A., Dement W.C., Barchas J.D., Eberwine J.H. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA. 87:1990;1663-1667.
13. Eberwine J., Yeh H., Miyashiro K., Cao Y., Nair S., Finnell R., Zettel M., Coleman P. Analysis of gene expression in single live neurons. Proc. Natl. Acad. Sci. USA. 89:1992;3010-3014.
14. Phillips J., Eberwine J.H. Antisense RNA amplification: a linear amplification method for analyzing the mRNA population from single living cells. Methods. 10:1996;283-288.
15. Mizuno Y., Sotomaru Y., Katsuzawa Y., Kono T., Meguro M., Oshimura M., Kawai J., Tomaru Y., Kiyosawa H., Nikaido I., Amanuma H., Hayashizaki Y., Okazaki Y. Asb4, Ata3, and Dcn are novel imprinted genes identified by high-throughput screening using RIKEN cDNA microarray. Biochem. Biophys. Res. Commun. 290:2002;1499-1505.
16. Miki R., Kadota K., Bono H., Mizuno Y., Tomaru Y., Carninci P., Itoh M., Shibata K., Kawai J., Konno H., Watanabe S., Sato K., Tokusumi Y., Kikuchi N., Ishii Y., Hamaguchi Y., Nishizuka I., Goto H., Nitanda H., Satomi S., Yoshiki A., Kusakabe M., DeRisi J.L., Eisen M.B., Iyer V.R., Brown P.O., Muramatsu M., Shimada H., Okazaki Y., Hayashizaki Y. Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse c DNA arrays. Proc. Natl. Acad. Sci. USA. 98:2001;2199-2204.
17. Kadota K., Miki R., Bono H., Shimizu K., Okazaki Y., Hayashizaki Y. Preprocessing implementation for microarray (PRIM): an effective method for processing cDNA microarray data. Physiol. Genom. 4:2001;183-188.
18. Eisen M.B., Spellman P.T., Brown P.O., Bostein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95:1998;14863-14869.
19. Pavlidis P., Noble W.S. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2:2001;1-15.
20. Popovici C., Adelaide J., Ollendorff V., Chaffanet M., Guasch G., Jacrot M., Leroux D., Birnbaum D., Pebusque M.J. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). Proc. Natl. Acad. Sci. USA. 95:1998;5712-5717.
21. Taki T., Kano H., Taniwaki M., Sako M., Yanagisawa M., Hayashi Y. AF5q31, a newly identified AF4-regulated gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q31q23). Proc. Natl. Acad. Sci. USA. 96:1999;14535-14540.
22. Iida S., Rao P.H., Butler M., Corradini P., Boccadoro M., Klein B., Chaganti R.S.K., Dalla-Favera R. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17:1997;226-230.
23. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G., Barfoot R., Hamoudi R.et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
24. Gold P., Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 121:1965;439-462.
25. Nurnberg P., Thiele H., Chandler D., Hohne W., Cunningham M.L., Ritter H., Leschik G., Uhlmann K., Mischung C., Harrop K., Goldblatt J., Borochowitz Z.U., Kotzot D., Westermann F., Mundlos S., Braun H.S., Laing N., Tinschert S. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat. Genet. 28:2001;37-41.
26. Hadjiargyrou M., Halsey M.F., Ahrens W., Rightmire E.P., McLeod K.J., Rubin C.T. Cloning of a novel cDNA expressed during the early stages of fracture healing. Biochem. Biophys. Res. Commun. 249:1998;879-884.
27. Laron Z., Klinger B., Erster B., Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinol. 121:1989;603-608.
28. Dent P., Lavoinne A., Nekielny S., Caudwell F.B., Watt P., Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature. 348:1990;302-308.
29. McAleer M.A., Breen M.A., White N.L., Matthews N. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem. 274:1999;23541-23548.